New research in JAMA finds a temporal association between SARS-CoV-2 infections and the onset of islet autoimmunity, a precursor to type 1 diabetes, in genetically predisposed infants. The study underscores COVID-19 as a potential risk factor for the development of this form of diabetes in young children.
MannKind's bright future sets it apart from many in the disappointing biotech industry. See why MNKD stock offers growth potential, but also a considerable risk.